Boston Scientific Buys Cameron Health For First Subcutaneous ICD

12 Mar 2012

Deal includes $150 million up front, but is worth up to $1.35 billion with potential milestone payments.

Boston Scientific Corp. expects to receive PMA approval for its newly acquired S-ICD subcutaneous implantable cardioverter defibrillator in the first half of 2013. The firm announced an agreement March 8 to acquire developer Cameron Health Inc. in a deal worth up to $1.35 billion.

If approved, the device would be the first subcutaneous implantable cardioverter defibrillator available in the U.S. The product, which eliminates...